DK141701B - Analogifremgangsmåde til fremstilling af 6-methyl-8-thiomethyl-ergolener eller -ergoliner eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 6-methyl-8-thiomethyl-ergolener eller -ergoliner eller syreadditionssalte deraf. Download PDF

Info

Publication number
DK141701B
DK141701B DK89375AA DK89375A DK141701B DK 141701 B DK141701 B DK 141701B DK 89375A A DK89375A A DK 89375AA DK 89375 A DK89375 A DK 89375A DK 141701 B DK141701 B DK 141701B
Authority
DK
Denmark
Prior art keywords
general formula
methyl
ergolines
compounds
preparation
Prior art date
Application number
DK89375AA
Other languages
Danish (da)
English (en)
Other versions
DK141701C (es
DK89375A (es
Inventor
Paul Stadler
Peter Stuetz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH356374A external-priority patent/CH593972A5/xx
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK89375A publication Critical patent/DK89375A/da
Publication of DK141701B publication Critical patent/DK141701B/da
Application granted granted Critical
Publication of DK141701C publication Critical patent/DK141701C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK89375AA 1974-03-14 1975-03-05 Analogifremgangsmåde til fremstilling af 6-methyl-8-thiomethyl-ergolener eller -ergoliner eller syreadditionssalte deraf. DK141701B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH356374A CH593972A5 (es) 1974-03-14 1974-03-14
CH356374 1974-03-14
CH1013874 1974-07-23
CH1013874 1974-07-23

Publications (3)

Publication Number Publication Date
DK89375A DK89375A (es) 1975-09-15
DK141701B true DK141701B (da) 1980-05-27
DK141701C DK141701C (es) 1980-10-20

Family

ID=25693324

Family Applications (1)

Application Number Title Priority Date Filing Date
DK89375AA DK141701B (da) 1974-03-14 1975-03-05 Analogifremgangsmåde til fremstilling af 6-methyl-8-thiomethyl-ergolener eller -ergoliner eller syreadditionssalte deraf.

Country Status (18)

Country Link
JP (1) JPS589111B2 (es)
AU (1) AU500890B2 (es)
CA (1) CA1071192A (es)
DD (1) DD118428A5 (es)
DE (1) DE2509471A1 (es)
DK (1) DK141701B (es)
ES (1) ES435538A1 (es)
FI (1) FI60865C (es)
FR (1) FR2263774B1 (es)
GB (1) GB1497681A (es)
HK (1) HK8481A (es)
IE (1) IE41533B1 (es)
IL (1) IL46809A (es)
MY (1) MY8100331A (es)
NL (1) NL7502807A (es)
NO (1) NO750748L (es)
PH (1) PH12966A (es)
SE (1) SE420094B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147789A (en) * 1974-03-14 1979-04-03 Sandoz Ltd. 6-Methyl-8-thiomethyl-ergolene derivatives
JPS5293797A (en) * 1976-01-30 1977-08-06 Sandoz Ag Improvement in organic compound
GB1555751A (en) * 1977-02-02 1979-11-14 Farmaceutici Italia Ergoline deritatives
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
GB2120242A (en) * 1982-04-30 1983-11-30 Erba Farmitalia Ergoline derivatives
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
IT1215261B (it) * 1985-04-05 1990-01-31 Poli Ind Chimica Spa Composizioni farmaceutiche adattivita' antigalattopoietica.
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6818658A (es) * 1968-01-18 1969-07-22

Also Published As

Publication number Publication date
DK141701C (es) 1980-10-20
SE7502469L (es) 1975-09-15
FI750644A (es) 1975-09-15
DD118428A5 (es) 1976-03-05
FR2263774B1 (es) 1978-08-04
NL7502807A (nl) 1975-09-16
HK8481A (en) 1981-03-20
JPS50123698A (es) 1975-09-29
GB1497681A (en) 1978-01-12
ES435538A1 (es) 1977-03-16
DK89375A (es) 1975-09-15
IE41533L (en) 1975-09-14
IL46809A0 (en) 1975-07-28
FR2263774A1 (es) 1975-10-10
FI60865C (fi) 1982-04-13
PH12966A (en) 1979-10-19
JPS589111B2 (ja) 1983-02-18
AU500890B2 (en) 1979-06-07
FI60865B (fi) 1981-12-31
IL46809A (en) 1978-04-30
CA1071192A (en) 1980-02-05
DE2509471A1 (de) 1975-09-18
AU7905775A (en) 1976-09-16
NO750748L (es) 1975-09-16
SE420094B (sv) 1981-09-14
IE41533B1 (en) 1980-01-30
MY8100331A (en) 1981-12-31

Similar Documents

Publication Publication Date Title
KR20220030257A (ko) Nav1.8 억제제로서의 2,3-디히드로퀴나졸린 화합물
KR20220042204A (ko) Rip1 억제 화합물 및 그를 제조 및 사용하는 방법
WO2010111626A2 (en) Poly (adp-ribose) polymerase (parp) inhibitors
JP2021511331A (ja) 心筋節阻害剤としてのジヒドロベンゾフランおよびインデンアナログ
WO2010085570A1 (en) Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
CN102007124A (zh) 嘧啶-2-胺化合物及其作为jak激酶抑制剂的用途
IL188181A (en) Monohydrate of 2- (6-methyl-pyridine-2-yl) -3-) 6-amido-quinoline-4-yl) -6,5-dihydro-h4-pyrrolo [2,1- b] pyrazole as an anti-drug Cancerous and pharmaceuticals containing it
AU2008245082A1 (en) Aminodihydrothiazine derivatives substituted with a cyclic group
WO2006017409A2 (en) 1,3-disubstituted heteroaryl nmda/nr2b antagonists
DK141701B (da) Analogifremgangsmåde til fremstilling af 6-methyl-8-thiomethyl-ergolener eller -ergoliner eller syreadditionssalte deraf.
WO2015097713A1 (en) Novel heterocyclic compounds
JP2021529746A (ja) 心臓サルコメア阻害剤
JP7301758B2 (ja) 縮合二環式化合物、その組成物及び応用
WO2021039968A1 (ja) ２－アミノキナゾリノン誘導体
US6800623B2 (en) Method of treating schizophrenia
US4147789A (en) 6-Methyl-8-thiomethyl-ergolene derivatives
CZ290678B6 (cs) 3-Substituované 3,4,5,7-tetrahydropyrrolo[3´,4´: 4,5]thieno[2,3-d]pyrimidinové deriváty, způsob jejich přípravy a použití
DE69413112T2 (de) 5-HT3 Pyrrolopyrazinderivate
CN106188029B (zh) 二并环类间变性淋巴瘤激酶抑制剂
JP2023554430A (ja) Ｎａｖ１．８阻害剤としての含窒素２，３－ジヒドロキナゾリノン化合物
CN106146478B (zh) 三嗪衍生物类间变性淋巴瘤激酶抑制剂
DK144176B (da) Analogifremgangsmaade til fremstilling af 3-(1-piperazinyl)-pyrido (2,3-b)-pyraziner eller farmaceutisk acceptable salte heraf
KR790000927B1 (ko) 복소환 화합물의 제조방법
US20040122003A1 (en) Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions
TW202300490A (zh) 雜環rip1激酶抑制劑

Legal Events

Date Code Title Description
PBP Patent lapsed